Sleep disordered breathing (SDB) is common in cardiovascular patients. Patients after cardiac surgery will be screened for SDB with the ApnoeLink device at the beginning of cardiac Rehabilitation and then after 3 weeks and 3 months.
Objective(s) of the project * Evaluate the prevalence of sleep apnea after cardiac surgery * Compare results interindividually (group A vs. group B) and intraindividually (longitudinal assessment after 3 months) Outcome(s) * Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery * composite endpoint of events at 3 months (cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, revascularisation procedure, new atrial fibrillation and stroke) * change in 6-minute walking test (6-MWT) * impact of heart surgery on sleep apnoe
Study Type
OBSERVATIONAL
Enrollment
450
Screening for sleep disordered breathing with the ApnoeLink Air device
Zürcher RehaZentrum Wald
Wald, Switzerland
Change of SDB prevalence after cardiac surgery measured with ApnoeLink Air device
• Prevalence of sleep apnoe at day 1 and 20 of rehabilitation and 3 months after cardiac surgery assessed with the ApnoeLink Air device (ResMed)
Time frame: day 1, day 20, 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.